A series of bispyridines were examined for their bactericidal activities against in vitro, preformed, pure-culture plaques of selected oral plaque-forming bacteria. The antimicrobial activities of these agents were examined in relation to their molecular configurations. These studies demonstrated that the length of the interpyridine polymethylene group bridge and the length of the alkyl side chain were important determinants of antiplaque and antimicrobial efficacy. The most potent compounds of the bispyridine series were studied to determine the minimal conditions (concentration, duration, and frequency) of treatment required for likely clinical efficacy.
A series of bispyridines were examined for their bactericidal activities against in vitro, preformed, pure-culture plaques of selected oral plaque-forming bacteria. The antimicrobial activities of these agents were examined in relation to their molecular configurations. These studies demonstrated that the length of the interpyridine polymethylene group bridge and the length of the alkyl side chain were important determinants of antiplaque and antimicrobial efficacy. The most potent compounds of the bispyridine series were studied to determine the minimal conditions (concentration, duration, and frequency) of treatment required for likely clinical efficacy.
The removal of dental plaque by mechanical means achieves short-term remission of the clinical signs of gingivitis, periodontitis, and dental caries (7, 8, 15, 20) . The effective control of dental plaque by such techniques, however, is dependent on patient compliance and is further limited by failure to reach certain plaque-infected sites. Thus, there exists great therapeutic potential for the development of chemotherapeutic agents to assist in the prevention of these pandemic dental infections in humans (1, 11, 12) . Because supragingival plaque is adherent to tooth surfaces and is bathed in neither blood nor interstitial fluids, topical antimicrobial agents would appear to be of the greatest utility.
Previous studies have indicated that certain bispyridines possess antiplaque activity (O'Connor and Paris, unpublished observations) when assessed in an in vitro antiplaque screen (19) . One of these compounds, octenidine dihydrochloride (WIN 41464-2), has been the subject of preliminary evaluation for topical efficacy (4 (2, 3, 9, 13, 14) . Cultures were stored either lyophilized or frozen (-70°C). Experimental working culture stocks were maintained by passage twice monthly in fluid thioglycolate medium containing 20%o (vol/vol) meat extract and excess CaCO3 (17) .
In vitro plaque formation. Plaques were grown on ceramic hydroxylapatite slabs (1 x 1 cm) which were individually suspended on no. 26 gauge nichrome wire by a modification of methods described previously (17, 18) . Fluid thioglycolate cultures were used to inoculate a complex growth medium (10), which was supplemented with 5% (wt/vol) sucrose and 0.05% (wt/vol) Na2CO3. The wire-attached ceramic hydroxylapatite pieces were transferred to fresh medium for 3 consecutive days. All cultures were incubated at 37°C under an anaerobic atmosphere (GasPak; BBL Microbiology Systems). The in vitro plaques were then sorted according to girth and mass, and those plaques of a similar size were selected for assessment of agent efficacy.
at of bbpyridine efficacy. Efficacy of the bispyridines was determined by techniques described previously (17, 18 be bactericidal after only two daily 2-min treatments at a similar level. These data may be expressed in terms of the PBI, from which the CC may be computed (17) . The PBI is the integration of the effects of concentration (millimolar), duration (daily exposure time), and frequency of treatments (number of daily treatments necessary to kill the plaques) required to achieve a plaque bactericidal effect. The CC is computed by dividing the PBI for the bisbiguanide chlorhexidine by that for the particular test agent (17) . The computation of these indices facilitates a comparison of the in vitro efficacy of any agent within a series and also permits a ready comparison of agent efficacy, at least at the in vitro level, with that of the most extensively studied antiplaque agent, chlorhexidine. A CC of >1.0 indicates that an agent possesses greater plaque bactericidal potency than does the bisbiguanide.
For S. mutans NCTC 10449, the data indicate that bispyridines with methylene bridge lengths of nine carbons are the most potent agents within the bispyridine series (no. 16, 17, and 18; Table 3 ). In addition, the findings confirm that the ideal alkyl side chain corresponds to a length of between seven and nine carbons (compound no. 16, 17, 18 , and 21; Table 3 ). Studies with A. viscosus M-100 gave PBI and CC values similar to those shown for S. mutans (data not shown). Compounds with a CC of >1.55 (no. 16, 17, 18 , and 21) were examined further, and the activity was assessed against additional strain representatives of indigenous oral plaque-forming microorganisms (Table 4) . On the basis of these experiments, it was found that the most potent antiplaque compounds were no. 16 and 21, whereas no. 17 was extremely potent against the target Streptococcus species. The overall antimicrobial activity of compound no. 18 for additional strains was less impressive but was still comparable to that for both octenidine (no. 22) and chlorhexidine.
On the basis of the PBI computations for the most active agents (no. 16 and 21), it was predicted that these agents would be bactericidal at a concentration of approximately 0.75 mM if plaques were treated for 2 min twice daily for 4 successive days. This prediction was confirmed (Table 5) , and the results further indicated that both compounds (no. 16 and 21) were more efficacious than was octenidine or chlorhexidine.
DISCUSSION
A series of bispyridines were examined for bactericidal activity against pure culture, in vitro plaques of selected oral plaque-forming microorganisms. Thirteen compounds were judged to be equal or superior to chlorhexidine, an extensively studied antiplaque agent, by their ability to The bispyridines that were examined displayed a wide range of antiplaque activities. This was especially true for plaques of strain representatives of the most cariogenic and periodontopathic organisms examined, S. mutans and A. viscosus, respectively. The structural determinants found to be critical for bactericidal activity were the length of the carbon chain (polymethylene bridge) between the pyridine moieties and the length of the alkyl side chains. The correlation of structure with activity was applicable to all of the strains examined, with final determinations made by comparing the PBIs. Most strains had similar PBIs for the same agents, although those for S. sanguis and S. mitis were usually slightly higher, indicating a greater tolerance by these organisms to the bispyridines.
It is presently not possible to account for the differences in agent susceptibility among the various species. However, the effect of an agent against intact plaque is probably a function of both the inherent susceptibility of the test species and the barrier to permeation of an agent to the plaque depth, which is constituted by the cells and their adhesive and cohesive extracellular matrices. In these studies, agent activity, as it reflects both bactericidal properties and plaque permeation properties, appears to be predictable by consideration of the molecular configuration. It is apparent that the hydropho- (6, 16) . In vivo studies with octenidine have also suggested that the in vitro estimations of the minimal concentration required to achieve maximal efficacy in the absence of any other oral hygiene measures are also within the anticipated ranges (P. Robertson and R. Lobene, unpublished observations). 
